These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20626523)

  • 1. Old habits die hard: the quest for correct(ed) QT interval measurements.
    Husser D; Hindricks G
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):914-5. PubMed ID: 20626523
    [No Abstract]   [Full Text] [Related]  

  • 2. Preferred QT correction formula for the assessment of drug-induced QT interval prolongation.
    Chiladakis J; Kalogeropoulos A; Arvanitis P; Koutsogiannis N; Zagli F; Alexopoulos D
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):905-13. PubMed ID: 20233271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early afterdepolarizations, U waves, and torsades de pointes.
    Wu J; Wu J; Zipes DP
    Circulation; 2002 Feb; 105(6):675-6. PubMed ID: 11839619
    [No Abstract]   [Full Text] [Related]  

  • 4. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
    Wegener FT; Ehrlich JR; Hohnloser SH
    Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urban & Vogel Workshop. Atrial fibrillation--decision aids for ambulatory therapy].
    Herz; 1995 Dec; 20 Suppl 3():1-16. PubMed ID: 8582701
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed adaptation of ventricular repolarization after sudden changes in heart rate due to conversion of atrial fibrillation. A potential risk factor for proarrhythmia?
    Grom A; Faber TS; Brunner M; Bode C; Zehender M
    Europace; 2005 Mar; 7(2):113-21. PubMed ID: 15763525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E; Watson T; Lip GY
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation.
    Kim MH
    Expert Rev Clin Pharmacol; 2012 Mar; 5(2):163-71. PubMed ID: 22390559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amiodarone-induced torsade de pointes--five case reports].
    Kukla P; Słowiak-Lewińska T
    Kardiol Pol; 2004 Apr; 60(4):365-70; discussion 371. PubMed ID: 15226788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation: rate versus rhythm control.
    Amani F; Smith ES
    J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
    [No Abstract]   [Full Text] [Related]  

  • 15. Nifekalant enlarged the transmural activation-recovery interval difference as well as the peak-to-end interval on surface ECG in a patient with short-QT syndrome.
    Chinushi M; Sato A; Izumi D; Furushima H
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):877-80. PubMed ID: 22494577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs.
    Motokawa Y; Nakamura Y; Hagiwara-Nagasawa M; Goto A; Chiba K; Lubna NJ; Izumi-Nakaseko H; Ando K; Naito AT; Yamazaki H; Sugiyama A
    Cardiovasc Toxicol; 2018 Jun; 18(3):242-251. PubMed ID: 29139031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug-related morphological changes of the T wave.
    Tjäderborn M; Aunes-Jansson M; Samuelsson E; Frison L; Johansson S; Berggren A; Edvardsson N
    Scand Cardiovasc J; 2010 Aug; 44(4):215-22. PubMed ID: 20429697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.
    Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T
    Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antibiotic recipe for an arrhythmic disaster.
    McCutcheon K; Manga P
    Cardiovasc J Afr; 2015; 26(3):143-5. PubMed ID: 26592910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker.
    Takii E; Inage T; Yoshida T; Ohe M; Gondo T; Haraguchi G; Ito S; Kumanomido J; Imaizumi T; Fukuomoto Y
    Heart Vessels; 2016 Mar; 31(3):402-7. PubMed ID: 25787020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.